1,2-distearoylphosphatidylethanolamine has been researched along with Breast Cancer in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bu, YZ; Hu, YJ; Li, XQ; Liu, L; Liu, R; Lu, WL; Mu, LM; Wu, JS; Yan, Y; Zhang, JY | 1 |
| Barrajón-Catalán, E; Catania, A; Cicirata, F; Micol, V; Nicolosi, S | 1 |
| Barnert, S; Gubernator, J; Hrynyk, R; Kempińska, K; Korycińska, M; Kozubek, A; Lipka, D; Milczarek, M; Süss, R; Wietrzyk, J | 1 |
| Guo, XY; Liu, WZ; Pang, WH; Qiu, C; Wang, JC; Wei, L; Wei, W; Wu, YF; Yang, T; Yu, MZ; Zhang, Q | 1 |
| Chen, Z; Li, C; Li, L; Liu, B; Wang, F | 1 |
| Torchilin, VP; Wu, H; Zhu, L | 1 |
| Koo, OM; Onyuksel, H; Rubinstein, I | 1 |
| Benazzouz, F; Cordobes, MD; de Beco, V; Moretti, JL; Starzec, A | 1 |
8 other study(ies) available for 1,2-distearoylphosphatidylethanolamine and Breast Cancer
| Article | Year |
|---|---|
The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Breast Neoplasms; Caspases; Epirubicin; Female; Humans; Liposomes; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mitochondria; Phosphatidylethanolamines; Polyethylene Glycols; Reactive Oxygen Species; Tissue Distribution; Xenograft Model Antitumor Assays | 2017 |
Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells.
Topics: Antibodies, Monoclonal, Humanized; Anticarcinogenic Agents; Antineoplastic Agents; Biological Availability; Biological Products; Breast Neoplasms; Carcinoma, Ductal, Breast; Cell Division; Cell Line, Tumor; Cholesterol; Chromatography, High Pressure Liquid; Curcumin; Drug Compounding; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Immunoconjugates; Liposomes; Neoplasm Proteins; Particle Size; Phosphatidylcholines; Phosphatidylethanolamines; Receptor, ErbB-2; Resveratrol; Stilbenes; Trastuzumab | 2013 |
Efficient human breast cancer xenograft regression after a single treatment with a novel liposomal formulation of epirubicin prepared using the EDTA ion gradient method.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Chemistry, Pharmaceutical; Cholesterol; Edetic Acid; Epirubicin; Humans; Kinetics; Liposomes; Male; Mice; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2014 |
Systemic delivery of siRNA by T7 peptide modified core-shell nanoparticles for targeted therapy of breast cancer.
Topics: Animals; Breast Neoplasms; Cell Proliferation; Collagen Type IV; ErbB Receptors; Female; Humans; Interferon-gamma; Interleukin-6; MCF-7 Cells; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Peptide Fragments; Phosphatidylethanolamines; Polyethylene Glycols; RNA Interference; RNA, Small Interfering; Tissue Distribution; Tumor Burden | 2016 |
Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Drug Carriers; Drug Liberation; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; HeLa Cells; Humans; Hyaluronic Acid; Lipids; MCF-7 Cells; Mice; Mice, Inbred BALB C; Nanoparticles; Paclitaxel; Particle Size; Phosphatidylethanolamines; Poloxamer; Tissue Distribution; Uterine Cervical Neoplasms | 2017 |
pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cytosol; Diffusion; Hydrogen-Ion Concentration; Mice; Micelles; Nanocapsules; Paclitaxel; Phosphatidylethanolamines; Polyethylene Glycols; Proteins | 2013 |
Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Topics: Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Capsules; Cell Line, Tumor; Cell Survival; Drug Compounding; Drug Stability; Humans; Liposomes; Micelles; Nanomedicine; Nanoparticles; Particle Size; Phosphatidylethanolamines; Solubility; Stereoisomerism | 2005 |
Uptake of liposome-encapsulated 99Tcm-MIBI by sensitive and multidrug-resistant tumour cell lines.
Topics: Adenocarcinoma; Biological Transport; Breast Neoplasms; Carcinoma, Small Cell; Cholesterol; Drug Resistance, Multiple; Female; Humans; Kinetics; Liposomes; Lung Neoplasms; Mouth Neoplasms; Phosphatidylcholines; Phosphatidylethanolamines; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tumor Cells, Cultured | 1999 |